- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glial Cell Tumors in Argentina
Total 445 results
-
Laboratorio Elea Phoenix S.A.Completed
-
José Mordoh, M.D., Ph.D.Completed
-
Laboratorio Pablo Cassará S.R.L.National Council of Scientific and Technical Research, Argentina; Fundacion... and other collaboratorsUnknownCutaneous MelanomaArgentina
-
Laboratorio Elea Phoenix S.A.Ministerio de Ciencia e Innovación, SpainCompletedGlioma | Neuroblastoma | Retinoblastoma | Wilm's Tumor | Ewing's SarcomaArgentina
-
Abramson Cancer Center at Penn MedicineGuerbetActive, not recruitingLiver Metastases | Neuroendocrine Tumor, MalignantUnited States, Canada, Italy, Argentina
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
Hospital Italiano de Buenos AiresUniversity of Buenos Aires; National Council of Scientific and Technical Research... and other collaboratorsTerminated
-
Austral University, ArgentinaCompletedNodular Goiter | Medullary Thyroid CarcinomaArgentina
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Centro Oncologico de ExcelenciaUnknownBreast Cancer | Colorectal Cancer | Melanoma (Skin)Argentina
-
Hospital JP GarrahanCompleted
-
National Council of Scientific and Technical Research...RecruitingPediatric Solid TumorsArgentina
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia Group; Italian Association for Pediatric Hematology...CompletedBrain and Central Nervous System TumorsCanada, United Kingdom, Netherlands, Spain, Sweden, Argentina, Italy
-
Mela Osorio Maria JoseJanssen-Cilag Ltd.Completed
-
Hospital JP GarrahanHospital San Juan de Dios, SantiagoActive, not recruitingUnilateral RetinoblastomaArgentina
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
AVEO Pharmaceuticals, Inc.TerminatedSafety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor MalignanciesTumorUnited States, Argentina
-
Laboratorio Elea Phoenix S.A.CompletedAdvanced Non-small Cell Lung CancerArgentina
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaArgentina
-
Crinetics Pharmaceuticals Inc.Active, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid | Carcinoid Tumor of Ileum | Carcinoid Tumor of Cecum | Carcinoid Syndrome Diarrhea | Carcinoid Intestine Tumor | Carcinoid Tumor of Liver | Carcinoid Tumor of PancreasUnited States, Brazil, Argentina, Canada, Mexico, Peru, Poland
-
University of ZurichTerminatedLiver Tumors Not Resectable in One Surgical ProcedureUnited States, Argentina, Switzerland
-
Laboratorio Elea Phoenix S.A.Syneos HealthRecruitingNon Small Cell Lung Cancer MetastaticArgentina
-
Hoffmann-La RocheCompletedCarcinoma, Non-small-cell LungArgentina
-
NYU Langone HealthWithdrawnSarcoma | Brain and Central Nervous System Tumors | Neuroblastoma | RetinoblastomaUnited States, Canada, Argentina
-
Hoffmann-La RocheCompletedUrothelial CarcinomaArgentina
-
Laboratorio Elea Phoenix S.A.CompletedSquamous Cell Carcinoma of the Cervix | Adenocarcinoma of the CervixArgentina
-
AstraZenecaCompletedMelanomaUnited States, Australia, Brazil, United Kingdom, Argentina, Austria, Canada, Denmark, France, Switzerland
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
PfizerCompletedHepatocellular Carcinoma | Advanced Breast Cancer | Non-Small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Renal Cell Cancer | Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Gastrointestinal Stromal Tumor | Advanced Gastric Cancer | Metastatic Castration Resistant Prostate Cancer | Advanced... and other conditionsUnited States, Spain, Korea, Republic of, France, Australia, United Kingdom, Canada, Brazil, Argentina, Taiwan, Belgium, Colombia, Germany, Hong Kong, Mexico, Philippines, Singapore
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
International Atomic Energy AgencyPostgraduate Institute of Medical Education and Research; Ege University; Dr... and other collaboratorsCompletedGlioblastoma MultiformeArgentina, Belarus, Brazil, Canada, Chile, Estonia, Georgia, India, Indonesia, Ireland, Poland, Thailand, Tunisia, Turkey
-
University of Buenos AiresMerck Sharp & Dohme LLCCompletedCondylomata AcuminataArgentina
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Belgium, Germany, Argentina, Australia, France, Israel, Netherlands, Switzerland, United States, United Kingdom, Norway
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Brazil, Chile, Mexico
-
TakedaCompletedCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseArgentina
-
AstraZenecaCompletedMelanomaUnited States, Italy, Spain, Sweden, Belgium, Canada, Poland, Switzerland, France, Russian Federation, United Kingdom, Australia, Argentina, Germany, Netherlands, Israel, South Africa, Austria, Greece, Mexico, Slovakia
-
Monte Verde SAFLENI Instituto de Rehabilitación y Educación Terapéutica, BA, Argentina.; Bioanalytical... and other collaboratorsCompletedBrain Neoplasms, Malignant, PrimaryArgentina
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, United States, Germany, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Greece, Israel, Mexico, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Brazil, France, Italy, South Africa, United Kingdom, Argentina, Australia, Canada, Ireland, Israel, Russian Federation, Spain, Belgium, Germany, Portugal, Chile, Austria, Poland, Netherlands, Ukraine, Czech Republic, ... and more
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more